These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1289101

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Tissue-type plasminogen activator (t-PA): comments on results of the GISSI-2 study].
    Turazza FM.
    Medicina (Firenze); 1990; 10(2):193-4. PubMed ID: 2125681
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
    Lancet; 1990 Jul 14; 336(8707):71-5. PubMed ID: 1975322
    [Abstract] [Full Text] [Related]

  • 26. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
    Kaul P, Armstrong PW, Chang WC, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB.
    Circulation; 2004 Sep 28; 110(13):1754-60. PubMed ID: 15381645
    [Abstract] [Full Text] [Related]

  • 27. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W, Schmutzler H.
    Herz; 1994 Dec 28; 19(6):336-52. PubMed ID: 7843690
    [Abstract] [Full Text] [Related]

  • 28. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
    Lancet; 1992 Mar 28; 339(8796):753-70. PubMed ID: 1347801
    [Abstract] [Full Text] [Related]

  • 29. Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico (GISSI).
    Lancet; 1987 Oct 17; 2(8564):871-4. PubMed ID: 2889079
    [Abstract] [Full Text] [Related]

  • 30. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators.
    N Engl J Med; 1993 Sep 02; 329(10):673-82. PubMed ID: 8204123
    [Abstract] [Full Text] [Related]

  • 31. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base.
    Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G.
    Circulation; 1993 Aug 02; 88(2):416-29. PubMed ID: 8339405
    [Abstract] [Full Text] [Related]

  • 32. Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).
    Maggioni AP, Franzosi MG, Farina ML, Santoro E, Celani MG, Ricci S, Tognoni G.
    BMJ; 1991 Jun 15; 302(6790):1428-31. PubMed ID: 2070108
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
    J Am Coll Cardiol; 1996 Feb 15; 27(2):337-44. PubMed ID: 8557903
    [Abstract] [Full Text] [Related]

  • 35. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial.
    Marino P, Zanolla L, Zardini P.
    J Am Coll Cardiol; 1989 Nov 01; 14(5):1149-58. PubMed ID: 2681320
    [Abstract] [Full Text] [Related]

  • 36. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
    Ital Heart J; 2000 Dec 01; 1(12):810-20. PubMed ID: 11302109
    [Abstract] [Full Text] [Related]

  • 37. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database.
    Volpi A, Cavalli A, Santoro L, Negri E.
    Am J Cardiol; 1998 Aug 01; 82(3):265-71. PubMed ID: 9708651
    [Abstract] [Full Text] [Related]

  • 38. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.
    Barlera S, Tavazzi L, Franzosi MG, Marchioli R, Raimondi E, Masson S, Urso R, Lucci D, Nicolosi GL, Maggioni AP, Tognoni G, GISSI-HF Investigators.
    Circ Heart Fail; 2013 Jan 01; 6(1):31-9. PubMed ID: 23152490
    [Abstract] [Full Text] [Related]

  • 39. Streptokinase in recent myocardial infarction: a controlled multicentre trial. European working party.
    European Working Party.
    Br Med J; 1971 Aug 07; 3(5770):325-31. PubMed ID: 4934187
    [Abstract] [Full Text] [Related]

  • 40. GISSI trial: early results and late follow-up. Gruppo Italiano per la Sperimentazione della Streptochinasi nell'Infarto Miocardico.
    Rovelli F, De Vita C, Feruglio GA, Lotto A, Selvini A, Tognoni G.
    J Am Coll Cardiol; 1987 Nov 07; 10(5 Suppl B):33B-39B. PubMed ID: 3312371
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.